Claims
- 1. A water soluble hybrid phthalocyanine derivative.
- 2. A derivative of claim 1 wherein the derivative is silicon[di(1,6-diphenyl-2, 3 naphthalocyanine)]diphthalocyanine bis [poly(ethylene glycol) methyl ether].
- 3. A derivative of claim 1 wherein the derivative is silicon[di(1,6-diphenyl-2, 3-naphthalocyanine)]diphthalocyanine bis[poly(ethylene glycol)].
- 4. A derivative of claim 1 wherein the derivative is silicon [di(1,6-diphenyl-2, 3-naphthalocyanine)] diphthalocyanine [poly(ethylene glycol)][poly(ethylene glycol)acetylthiopropionate].
- 5. A derivative of claim 1 wherein the derivative is silicon[di(1,6-diphenyl 2,3-naphthalocyanine)]di(2,3-dicarboxyphthalocyanine)dihydroxide.
- 6. A derivative of claim 1 wherein the derivative is silicon[di(1,6-diphenyl 2,3-naphthalocyanine)]di(2,3-dicarboxyphthalocyanine) bis[poly(ethylene glycol)methyl ether].
- 7. A derivative of claim 1 wherein the derivative is sulfo silicon di[(1,6-diphenyl-2, 3-naphthalocyanine] diphthalocyanine dihydroxide.
- 8. A derivative of claim 1 wherein the derivative is silicon [di(1,6-diphenyl-2, 3-naphthalocyanine)] diphthalocyanine [poly(ethylene glycol)][poly(ethylene glycol)thiopropionate].
- 9. A derivative of claim 1 wherein the derivative is sulfo silicon di[(1,6-diphenyl-2, 3-naphthalocyanine]diphthalocyanine[-2-butyrothiolactone) amidomethoxide]hydroxide.
- 10. A derivative of claim 1 wherein the derivative is sulfo silicon di[(1,6-diphenyl-2, 3-naphthalocyanine]diphthalocyanine[N-(cysteine)amidomethoxide]hydroxide.
- 11. A derivative of claim 1 wherein the derivative is silicon tetra-tert-butylphthalocyanine bis [(4-aminobutyl) dimethylsilyloxide].
- 12. A derivative of claim 1 wherein the derivative is sulfo[21,26,121,126-tetraphenyldinaphtho [b,l]-7,17-dibenzo[g,q]-5,10,15,20-tetraazoporphyrinato]silicon dihydroxide.
- 13. A derivative of claim 1 wherein the derivative is sulfo[21,26,121,126-tetraphenyldinaphtho [b,l]-7,17-dibenzo[g,q]-5,10,15,20-tetraazoporphyrinato]silicon bis (4-Aminobutyldimethylsilyloxide).
- 14. A derivative of claim 1 wherein the derivative is sulfo[21,26,121,126-tetraphenyldinaphtho [b,l]-7,17-dibenzo[g,q]-5,10,15,20-tetraazoporphyrinato]silicon bis (3-amino-propyldiisopropylsilyloxide).
- 15. A derivative of claim 1 wherein the derivative is sulfo[21,26,121,126-tetraphenyldinaphtho [b,l]-7,17-dibenzo[g,q]-5,10,15,20-tetraazoporphyrinato]silicon bis-[(10-carbomethoxydecyl) dimethyl silyloxide].
- 16. A derivative of claim 1 wherein the derivative is sulfo[21,26,121,126-tetraphenyldinaphtho [b,l]-7,17-dibenzo[g,q]-5,10,15,20-tetraazoporphyrinato]silicon bis (7-oct-1-enyldimethylsilyloxide).
- 17. A derivative of claim 1 wherein the derivative is sulfo silicon naphthalocyanine bis(4-aminobutyldimethyl silyloxide).
- 18. A derivative of claim 1 wherein the derivative is sulfo silicon naphthalocyanine bis [10-(carbomethoxy)decyl dimethylsilyloxide].
- 19. A derivative of claim 1 wherein the derivative is sulfo silicon naphthalocyanine bis(3-aminopropyldiisopropylsilyloxide).
- 20. A derivative of claim 1 wherein the derivative is sulfo[21,26,121,126-tetraphenyldinaphtho [b,l]-7,17-dibenzo[g,q]-5,10,15,20-tetraazoporphyrinato]silicon bis[N-succinamido) aminobutyldimethyl silyloxide.
- 21. A derivative of claim 1 wherein the derivative is sulfo[21,26,121,126-tetraphenyldinaphtho [b,l]-7,17-dibenzo(g,q]-5,10,15,20-tetraazoporphyrinato]silicon bis[4[(acetylthiopropionamido)butyl] dimethylsilyloxide].
- 22. A derivative of claim 1 wherein the derivative is sulfo[21,26,121,126-tetraphenyldinaphtho [b,l]-7,17-dibenzo[g,q]-5,10,15,20-tetraazoporphyrinato]silicon bis[4[(thiopropionamido)butyl] dimethylsilyloxide].
- 23. A conjugate comprising a sulfonated hybrid phthalocyanine derivative and a substituent.
- 24. A conjugate of claim 23 wherein the substituent is an antibody.
- 25. A conjugate of claim 24 wherein the antibody specifically binds to human chorionic gonadotropin.
- 26. A conjugate of claim 23 wherein the substituent is a ligand analogue.
- 27. The conjugate of claim 26 wherein the ligand analogue is morphine.
- 28. A method for determining the presence or amount of at least one target ligand capable of competing with a ligand analogue conjugate for binding sites available on a ligand receptor, said ligand analogue conjugate comprising at least one ligand analogue coupled to a signal development element, said signal development element comprising a water soluble phthalocyanine derivative, in a fluid sample suspected of containing said target ligand comprising the steps of:
a. contacting said fluid sample with said ligand analogue conjugate and said ligand receptor to form a homogeneous reaction mixture; b. detecting bound or unbound ligand analogue conjugates in said reaction mixture using said water soluble phthalocyanine derivative; and, c. relating the detectable signal to the presence or amount of said target ligand in said fluid sample.
- 29. A method of determining the presence or amount of at least one ligand in a fluid sample suspected of containing said target ligand comprising the steps of:
a. contacting said fluid sample with a receptor said receptor coupled to a signal development element comprising a water soluble phthalocyanine derivative, so that said receptor specifically binds said target ligand to form a homogeneous reaction mixture; b. detecting bound receptor in said reaction mixture using said water soluble phthalocyanine derivative; and, c. relating the detectable signal to the presence or amount of said target ligand in said fluid sample.
Priority Claims (1)
Number |
Date |
Country |
Kind |
PCT/US94/10826 |
Sep 1994 |
US |
|
REFERENCE TO RELATED APPLICATIONS AND PATENTS
[0001] This application is a continuation in part of U.S. patent application Ser. No. 08/409,298, which is a continuation in part of U.S. patent application Ser. No. 08/274,534, filed Jul. 12, 1994 (abandoned), and of U.S. patent application Ser. No. 08/138,708, filed Oct. 18, 1993 (abandoned), and of U.S. patent application Ser. No. 08/126,367, filed Sep. 24, 1993 (abandoned), and of U.S. patent application Ser. No. 08/311,098, issued as U.S. Pat. No. 5,763,189 on Jun. 9, 1998, and of U.S. patent application Ser. No. 08/409,825, filed Mar. 23, 1995 (abandoned); and a continuation in part of U.S. patent application Ser. No. 09/066,255, which is a continuation of U.S. patent application Ser. No. 08/620,597, which issued as U.S. Pat. No. 5,824,799 on Oct. 20, 1998, which is a continuation in part of U.S. patent application Ser. No. 08/274,534, filed Jul. 12, 1994 (abandoned), and of U.S. patent application Ser. No. 08/138,708, filed Oct. 18, 1993 (abandoned), and of U.S. patent application Ser. No. 08/126,367, filed Sep. 24, 1993 (abandoned), and of U.S. patent application Ser. No. 08/311,098, issued as U.S. Pat. No. 5,763,189 on Jun. 9, 1998, and U.S. patent application Ser. No. 08/409,825, filed Mar. 23, 1995 (abandoned); from each of which priority is claimed, and each of which are hereby fully incorporated by reference herein.
Continuations (1)
|
Number |
Date |
Country |
Parent |
08620597 |
Mar 1996 |
US |
Child |
09066255 |
Apr 1998 |
US |
Continuation in Parts (7)
|
Number |
Date |
Country |
Parent |
08409298 |
Mar 1995 |
US |
Child |
09776599 |
Feb 2001 |
US |
Parent |
08274534 |
Jul 1994 |
US |
Child |
08409298 |
Mar 1995 |
US |
Parent |
08138708 |
Oct 1993 |
US |
Child |
08409298 |
Mar 1995 |
US |
Parent |
08126367 |
Sep 1993 |
US |
Child |
08409298 |
Mar 1995 |
US |
Parent |
08311098 |
Sep 1994 |
US |
Child |
08409298 |
Mar 1995 |
US |
Parent |
08409825 |
Mar 1995 |
US |
Child |
08409298 |
Mar 1995 |
US |
Parent |
09066255 |
Apr 1998 |
US |
Child |
08409298 |
Mar 1995 |
US |